Absolute Investment Advisers »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Absolute Investment Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Absolute Investment Advisers from 13F filings

Historical chart of Absolute Investment Advisers investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Absolute Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Absolute Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $11B 11M 980.80
2023-12-31 $10B 11M 928.75
2023-09-30 $8.5B 9.0M 939.70

More positions owned by Absolute Investment Advisers

Integer Hldgs Corp Note 2.125% 2/1
Infinera Corp Note 2.500% 3/0
Axon Enterprise Note 0.500%12/1
Patrick Inds Note 1.750%12/0
Impinj Note 1.125% 5/1
Pros Holdings Note 2.250% 9/1
Altair Engr Note 1.750% 6/1
Envestnet Note 2.625%12/0
Ormat Technologies Note 2.500% 7/1
Perficient Note 0.125%11/1
Bentley Sys Note 0.375% 7/0
Stride Note 1.125% 9/0
Workiva Note 1.125% 8/1
Greenbrier Cos Note 2.875% 4/1
Halozyme Therapeutics Note 1.000% 8/1

View all positions for Absolute Investment Advisers

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1